Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous B12 in children with autism
NCT00273650Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jul 2005
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of mecobalamin in Autism Spectrum Disorder (ASD), sponsored by University of California, San Francisco. Started Jul 2005; status: completed.
02
Drugs
mecobalamin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00273650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273650.